Recent studies have found a higher frequency of the PTEN tumor-suppressor gene alterations in invasive bladder carcinoma than in superficial disease, suggesting that PTEN is important in this process. A role of PTEN in bladder cancer invasion is further suggested by the fact that PTEN is a regulator of cell motility, a necessary component of tumor invasion. However, it is unknown whether PTEN is mechanistically involved in 'in vivo' tumor invasion or merely an epiphenomenon and, if the former is true, whether this process is dependent on its protein or lipid phosphatase activities. To address these issues, we stably transfected several commonly used human bladder cancer cell lines with known invasive phenotypes with either wild-type PTEN constructs or those deficient in the lipid phosphatase (G129E) or both protein and lipid phosphatase (G129R) activities. Here we show that chemotaxis was inhibited by both the wild-type and G129E mutant of PTEN but not by G129R-transfected cells. Using a novel organotypic in vitro invasion assay, we evaluated the impact of wild-type and mutant PTEN transgene expression on the invasive ability of T24T, a human bladder cancer cell line with a functionally impaired PTEN. Results indicate that the G129E mutant blocks invasion as efficiently as wild-type PTEN transfection. In contrast to the wild-type gene, this mutant has no effect on cell clonogenicity in agar. To further establish the role of PTEN in tumor invasion, we evaluated vector-and PTEN-transfected T24T cells in an orthotopic in vivo assay that faithfully reproduces human disease. Microscopic examination of murine bladders at the completion of this experiment parallels the results obtained with the organotypic assay. Our results are the first demonstration: (1) that the inhibitory effects of PTEN on cell motility translate into suppression of in vivo invasion; (2) that PTEN can inhibit tumor invasion even in the absence of its lipid phosphatase activity; (3) how organotypic in vitro approaches can be used as surrogates of in vivo invasion allowing rapid dissection of molecular processes leading to this phenotype while reducing the number of animals used in research.
Introduction
Transitional cell carcinoma (TCC) of the bladder, the most common form of bladder cancer, manifests in two distinct forms with quite different clinical and biological behaviors. In all, 70% of patients present with 'superficial' tumors which do not invade the muscle of the bladder wall, and have an overall good prognosis. A 'muscle invasive' form of disease occurs in the remaining 30% of patients (Skinner et al., 1998) . Importantly, 10-45% of the superficial cases progress to an invasive form of the disease (Heney et al., 1983) , which results in a much worse prognosis. Multiple genetic and phenotypic markers have been investigated in an attempt to identify the underlying cause of this progression and allow more meaningful categorization of prognostic groups (Lianes et al., 1998) .
The tumor-suppressor gene PTEN has come under scrutiny for its possible involvement in bladder cancer progression. PTEN, also known as MMAC1 or TEP1, is located at human chromosome band 10q23, and is lost or mutated in glioma, breast, prostate, kidney and bladder tumor specimens and cell lines (Vazquez and Sellers, 2000; Simpson and Parsons, 2001) . PTEN was also identified as the gene predisposing to Cowden disease, an autosomal dominant cancer predisposition syndrome associated with an increased risk of breast, skin and thyroid tumors and occasional cases of bladder and renal cell carcinoma (Li et al., 1997; Steck et al., 1997) . Several investigators have specifically looked at loss of 10q23 and/or PTEN mutation in bladder cancers (Cappellen et al., 1997; Cairns et al., 1998; Aveyard et al., 1999; Wang et al., 2000) . While these studies indicate that the PTEN gene is altered only in a minority of bladder cancers, its loss appears associated with a more invasive and malignant phenotype.
The PTEN gene encodes a protein with phosphatase activity directed toward a variety of phosphoprotein and phospholipid substrates (Vazquez and Sellers, 2000; Simpson and Parsons, 2001) . In vitro, PTEN can remove the phosphate from phosphotyrosine, and phosphoserine/threonine-containing peptides, thus its protein phosphatase effects. It is also a potent phosphatase for the phosphate at the D3 position of phosphatidyl inositols, and thus can be seen as antagonizing the activity of phosphatidylinositol 3 kinase (PI3K) Dixon, 1998, 1999) . All of the known naturally occurring mutations of PTEN lack the lipid phosphatase activity, indicating a critical role for these substrates in tumorigenicity. The role of PTEN's protein phosphatase activity in tumor biology is less well understood, but it is believed to act on the cells' motility pathways in vitro (Tamura et al., 1998 (Tamura et al., , 1999a . In addition, PTEN protein phosphatase activity also regulates in vitro invasion (Maier et al., 1999; Tamura et al., 1999a) .
We have previously shown that PI3K activity is a necessary component of an EGF-mediated chemotaxis pathway in human bladder cancer (Theodorescu et al., 1998; Gildea et al., 2002a) . Since EGF receptor (EGFR) overexpression is a predictor for progression of superficial bladder cancer toward the invasive phenotype (Lipponen and Eskelinen, 1994) , this suggests that PTEN may exert its invasion suppression effects via its activity as a potent antagonist of PI3K Dixon, 1998, 1999) . However, the data described above also implicate the PTEN protein phosphatase in in vitro cellular invasion (Maier et al., 1999; Tamura et al., 1999b) . Taken together, it would appear that in noninvasive cells, PTEN may act to block invasion via both its protein and lipid phosphatase activities. Whether blockade of either one or both of these pathways is sufficient to interdict invasion in cells which lack functional PTEN remains to be determined.
The study of the functional implications of the various activities of PTEN has been aided by naturally occurring mutations which alter its substrate specificity. Some mutations abolish both lipid and protein phosphatase activity, exemplified by the G129R mutation, and some such as G129E retain the ability to dephosphorylate proteins while losing their lipid phosphatase activity (Furnari et al., 1998; Myers et al., 1998) .
In light of the association of PTEN loss with human bladder cancer invasion, we sought to address the following questions: (1) does PTEN regulate tumor invasion in vivo?; (2) is the lipid phosphatase activity of PTEN necessary in tumor invasion in vivo? We addressed these questions by evaluating wellcharacterized human bladder cancer cell lines using a novel in vitro organotypic invasion assay and in an in vivo orthotopic system which faithfully replicates the human disease (Theodorescu et al., 1990) .
Results

PTEN expression levels in bladder cell lines
We began our characterization of the role of PTEN in regulating bladder cancer cell phenotype by determining the expression of the endogenous gene in immortalized 'normal' bladder cells and several commonly used human bladder cancer cell lines including our T24 and T24T cells. Prostate cancer cell lines whose PTEN status has been well documented were also included for comparison. Western blotting with a PTEN-specific antibody (Figure 1a ) revealed the expression of PTEN (PI3KDN), wild-type PTEN (wtPTEN) or control vector (PBABE). T24, T24T, HT1197 and UM-UC-3 cells were transiently transfected, subjected to rapid selection as in Materials and methods, and then used in the assay. Cells were placed in transwell chemotaxis chambers sitting in Boyden chambers and incubated for 6 h before assaying for cells that migrated through the filter. The motile fraction of cells was calculated as the ratio of fluorescence measured from lysed cells from the undersurface of the filter divided by the fluorescence measured from an equal number of cells placed in a replica well. Error bars represent one standard deviation from the mean of triplicate samples. Data are representative of two independent experiments with similar results. (c) Stable transfection of PTEN transgenes into T24T cells and analysis of PTEN protein expression in clones. After long-term selection in puromycin, resistant 'pools' of wild-type PTEN (W), G129E mutant PTEN (E), G129R mutant PTEN (R) and PBABE vector (V) transfected cells were obtained. Individual cell clones were isolated from the pools and are referred to as W1-6 for wild type. The UM-UC-3 cell line lacking PTEN (UM) was used for comparison. Protein expression of the PTEN transgene detected by Western blotting with a PTEN-specific antibody is shown. * Indicates clones used for subsequent characterization protein by the immortalized bladder cells HUC E7 as well as in the RT4, T24, T24T, bladder cancer cells and in the DU145 prostate cancer cell line. Three cell lines, the UMUC3 and J82 bladder cancer and the LNCaP prostate cancer cells, did not express any detectable PTEN. RT4 and DU145 were already known to express wild-type PTEN (30) and UMUC3, J82 and LNCaP were known to have PTEN gene alterations that abolish PTEN expression (6, 7, 11, 31) . In conclusion, PTEN expression levels in T24 and T24T were similar to those harboring a wild-type PTEN and thus their endogenous level can be used as a standard for the selection of cells harboring transfected PTEN constructs.
PTEN can inhibit the motility of bladder cancer cells with functionally deficient PTEN
We previously found that serum and EGF-stimulated motility of T24 was inhibited by the PI3K inhibitors Wortmanin and LY294002 (Theodorescu et al., 1998; Gildea et al., 2002a) . Since PTEN opposes PI3K activity, we hypothesized that PTEN would inhibit serum-stimulated bladder cell chemotaxis. The current experiments sought to test this hypothesis in T24 and T24T. Transwell chemotaxis assays were performed using cells transiently transfected with an expression construct for wild-type PTEN (wtPTEN). T24 and T24T cells as well as those with a PTEN wild-type (HT1197) or null genotype (UM-UC-3) were evaluated. Dominant-negative PI3K and vector were transfected into a parallel set of cells for comparison. Figure 1b shows that when wtPTEN inhibited cell migration the magnitude of this inhibition was comparable to dominant-negative PI3K. T24 and T24T cell lines appear similarly sensitive to the motility inhibitory effects of PI3K inhibition and PTEN reconstitution as a PTEN null cell line. In contrast, these data show that transfection of wild-type PTEN in a cell line without a PTEN defect does not result in alteration of cell migration. We have also noted that PTEN transfection does not change cellular morphology of the bladder cell lines as observed by routine microscopy (data not shown).
Establishment of PTEN transgene expressing T24T cells
To investigate the importance of the two functional activities of PTEN on T24T, cells were transfected with either vector, HA-tagged wtPTEN, HA-tagged G129R mutant PTEN or the HA-tagged G129E mutant PTEN expression constructs. After selection of puromycinresistant cultures, these 'pools' were screened for expression of the transgene. In addition, individual cell clones for the wtPTEN and G129E constructs were isolated and screened for expression. The presence of the HA epitope tag on the expression constructs allowed us to specifically assess the expression of the transgene and not endogenous PTEN. Initially, clones were screened by RT-PCR. The use of one primer corresponding to the coding region of the HA tag facilitated discrimination of the transgene. Approximately 50 clones from each pool were screened in this manner, and only clones which expressed the PTEN transgene were selected for further study (data not shown). In order to compare PTEN transgene expression, PTEN protein expression of the pools and selected clones was determined. A major consideration in pool and clonal selection was achieving transgene expression levels that were equal or slightly lower than the endogenous PTEN levels. We have not used any clones that have transgene expression levels higher than the endogenous gene specifically to maintain the physiological nature of these experiments.
As can be seen in Figure 1c , all pools and clones express the PTEN transgene. Although not readily visible on Western blot at the exposure shown, clone W5 does express the transgene at longer exposures and by the initial RT-PCR screening approach used to select the clones (data not shown). Clones W2, 4, 6 were selected for further study as their PTEN-HA protein transgene expressions were the highest (Figure 1c ). Clonal cell lines E1 and E2 derived by transfecting and expressing the G129E-HA mutant PTEN were selected by similar criteria (Figure 2a ).
The lipid phosphatase activity of PTEN suppresses colony formation in agar in a serum-dependent fashion T24T pools and clones (W2,4,6 and E1,2) expressing the transfected PTEN gene or vector control were evaluated with respect to their in vitro growth. Vector-transfected pooled puromycin-resistant cells were used as control. In addition, we also used the parental nontransfected cell line as an additional control to determine if the transfection or selection procedures altered the biology of these cells. CyQUANT assays were used to measure cellular proliferation on plastic tissue culture dishes over a 5-day period. No growth differences between any of the cell populations were seen in either low (2%) or high (10%) serum conditions (data not shown).
The ability of stable transfectants to form colonies when grown in suspension was examined. All pools of transfected T24T, irrespective of the transfected construct, formed colonies in soft agar to the same extent in high (10%) serum conditions (data not shown). However, when placed in low (2%) serum conditions, the wtPTEN pools made many fewer colonies, while the G129E and G129R pools behaved like vector control ( Figure 2b ). The clonal cell lines were similar to their respective pool of origin, except that some of the wtPTEN clones were suppressed even at high serum conditions (data not shown). Even when considering expression level differences, among the clones, these data suggest that the suppression of colony formation in agar is not related to the level of PTEN transgene expression without considering the mutational status. For example, clone E1 has B8 Â more PTEN transgene expressed compared to E2, yet its colony formation is marginally different. In contrast, W2 or W4 have only B2 Â more transgene PTEN expression than E1, yet the effect on colony formation is profound. Clearly, although a protein phosphatase effect on colony formation cannot be ruled out, the primary effect of the protein phosphatase does not appear to be on colony formation in agar. In conclusion, we confirm the literature that the lipid phosphatase activity of PTEN regulates soft agar colony formation in a serumdependent fashion, and suggests that the lipid phosphatase activity of PTEN may be critical for suppression of tumorigenicity by bladder cancer cells.
PTEN inhibits the motility of T24T cells despite inactivation of the lipid phosphatase activity
Since the motility of T24T cells is diminished by both PI3K inhibition and wild-type PTEN transfection (Figure 1b) , it would be natural to assume that PTEN exerts this effect on migration via its lipid phosphatase activity. However, as cited above, PTEN is known to affect migration via its protein phosphatase activity by influencing FAK activity, for example (Tamura et al., 1998 (Tamura et al., , 1999a , and the experiments above do not exclude this possibility. Hence, we sought to test the hypothesis that the lipid phosphatase activity of PTEN is necessary for inhibition of cell migration. By doing this, these experiments indirectly evaluate the role of the protein phosphatase activity of PTEN in affecting cell migration.
Transwell chemotaxis assays were performed with transiently and stably transfected T24T and UM-UC-3 cells using the three PTEN constructs at our disposal. In addition, the HT1197 cell line, which expresses low levels of endogenous wild-type PTEN, was transiently transfected with wtPTEN and assayed. Serum-stimulated chemotaxis was suppressed in T24T and UM-UC-3 cells by transient or stable transfection of the wild-type and G129E mutant PTEN transgenes but not the G129R mutant ( Figure 3a ). This demonstrates that the lipid phosphatase activity of the PTEN transgene is not necessary for the suppression of chemotaxis and suggests that the protein phosphatase activity may play a role in this process. In addition, since the motility of HT1197 cells was not suppressed by any of the PTEN constructs (Figures 1b and 3a) , this finding suggests that in cases where endogenous PTEN is wild type, further overexpression of the protein via transfection of a transgene does not affect cell motility.
This latter observation led us to hypothesize that if the clones we isolated (i.e. W2,4,6 and E1,2) had in fact a 'functionally repaired' PTEN-regulated migration pathway by virtue of a stably expressed transgene protein, no further effects on chemotaxis would be observed with transient wtPTEN transfection (despite the lipid phosphatase activity of this wtPTEN). Thus, we used T24T wtPTEN and G129E clones stably expressing a PTEN transgene and evaluated their motility response to further wtPTEN transfection. If the hypothesis proposed above is correct, the stable cell clones transfected with wtPTEN (i.e. W2,4,6) would not be further suppressed in motility by transient wtPTEN transfection. Similarly, if the lipid phosphatase activity of PTEN is not necessary for cell migration, G129E clones E1 and E2 (which predictably did not have suppression of clonogenicity in agar (Figure 2b ), since this phenotype is associated with an intact lipid phosphatase activity (Furnari et al., 1997 (Furnari et al., , 1998 , would not show further migration inhibition by transient wtPTEN transfection.
We transiently transfected the stable wtPTEN and G129E clones shown in Figure 2b with wtPTEN and carried out rapid selection followed by the transwell chemotaxis assay. Figure 3b shows that transient transfection of wtPTEN into parental and vectortransfected cells suppressed chemotactic motility, yet none of the stable clonal cell lines expressing the wtPTEN or G129E transgene exhibited further inhibition. This result further consolidates the notion that the lipid phosphatase activity of the PTEN transgene is not necessary for the suppression of chemotaxis. The lipid phosphatase activity of PTEN is not necessary for inhibition of organotypic invasion of T24T cells
In view of the findings above suggesting that loss of PTEN lipid phosphatase activity does not affect its ability to reduce cell motility, we sought to determine if this was also true for tumor invasion. We tested this hypothesis in a novel organotypic assay. A biologically relevant in vitro model to study the mechanisms of bladder cancer invasion would constitute a more convincing assessment of the relevance of particular genes to this process than classical in vitro assays of invasion. In addition, such an 'organoid' system would be a highly desirable 'in-between' stage bridging cell culture assays and in vivo orthotopic systems while allowing experiments, which would be impossible in either of the two systems. From a practical perspective, bladder cancer is an optimal organ system to study invasion due to its progressive invasive pattern into distinct anatomically defined layers of the bladder wall and also because organ culture systems are conceptually relatively simple to construct and to image.
Organ culture invasion assays were carried out with stably transfected T24T cells using the PTEN constructs at our disposal. Invasion in organ culture was suppressed in T24T cells stably transfected by wild-type and G129E mutant PTEN transgenes (Figure 4) . wtPTENand G129E-transfected cell lines had a marked reduction of tumor invasion compared to vector-transfected cells. This demonstrates that loss of the lipid phosphatase activity of the PTEN transgene does not impact its suppressive effect on tumor invasion. Given the previous results showing that the lipid phosphatase activity of PTEN was not necessary for the inhibition of in vitro motility and organotypic invasion, we sought to test the hypothesis that this enzymatic activity is also not needed for the suppression of invasion of T24T bladder cancer cells into the bladder wall in vivo. Two of the wild-type PTEN and two of the G129E mutant PTEN-expressing clones characterized in Figure 4 , as well as the vector-transfected pool, were used to measure orthotopic in vivo invasion. Mice were anesthetized and cells inoculated orthotopically as described (Theodorescu et al., 1990) .
As can be seen in Table 1 , the overall orthotopic tumorigenicity is 8/37 (22%). This number includes W2 and W4, two cell lines expressing a wild-type PTEN transgene and, as such, would be expected to have reduced (Po0.05) tumorigenicity (1/13, 7%) compared to control (3/8, 37%). Conversely, G129E-transfected cell lines would be expected to have normal tumor take (Furnari et al., 1997 (Furnari et al., , 1998 . In this group, a tumorigenicity of 4/16 (25%) was observed, which is consistent with published literature (Ahlering et al., 1987) and not significantly different from G129E-transfected cell lines. In the animals with intravesical tumors, careful examination of the depth of invasion was carried out. Some animals did not have any tumors (Figure 5a ) while others, such as those inoculated with the vectortransfected cells, exhibited an invasive phenotype (Figure 5b ). In contrast, cells transfected with the wildtype PTEN construct (clone W2 and W4), or the construct which retains only protein phosphatase activity (G129E), do not exhibit the invasive phenotype, but instead grow as superficial tumors in all cases ( Figure  5c,d) . These results mirror the data from the in vitro motility assays (Figure 3b ) and the organotypic assay ( Figure 4 ) and suggest that the lipid phosphatase activity of PTEN is not alone in the regulation of in vivo invasion.
Discussion
The T24 lineage cells used in these experiments are a faithful model of invasive human bladder cancer by virtue of their EGFR overexpression (Lipponen and Eskelinen, 1994), H-Ras mutation (Fontana et al., 1996) , functional inactivation of PTEN (Liu et al., 2000; Tanaka et al., 2000) , as well as by the invasive ability of T24T in orthotopic assays (Gildea et al., 2000a) . These cell lines are an excellent model in which to compare and contrast genetic and phenotypic differences associated with the acquisition of tumorigenicity and aggressiveness.
To our knowledge, the data presented here are the first description of stable cell lines generated by transfection of wild-type and mutant forms of PTEN into human cancer cells. This approach has the advantage of offering cells for study in long-term in vivo studies which are difficult to accomplish with transient gene transfer approaches. In addition, because (Figure 1b) . Owing to similar expression levels, these pooled populations can be compared in terms of colony formation in agar as well as cell motility. In addition, it is an important thing to emphasize that despite their low but similar expression levels of the transgene, these pooled populations behave as expected from the literature in regard to colony formation in agar, namely decrease in wild-type PTEN and similarity to vector control levels in G129E-and G129R-transfected cells, and motility, namely decrease in wild-type PTEN and in G129E but similarity to control levels in G129R-transfected cells.
Our data confirm previous reports that adenovirusmediated transfer of wild-type PTEN inhibits tumor growth by UM-UC-3 and T24 cells (Tanaka et al., 2000) . The T24 cells used in this study were probably most similar to our T24T cells, since they were tumorigenic (Liu et al., 2000) . In the setting of stable cell lines, expression of wtPTEN transgene comprising only a small fraction of the endogenous protein levels is associated with significant phenotypic changes. These phenotypes are similar to those exhibited by cells with complete loss of any PTEN protein production such as UM-UC-3. Conversely, no effect of wtPTEN transfection is seen in bladder cancer cells carrying a functional PTEN (HT1197). This differential response based on endogenous PTEN status has been seen in other systems, although the relationship appears cell type dependent. In glioblastoma cells, like in bladder cancer, PTEN gene transfer seems to arrest the cell cycle only in cells lacking PTEN expression, and this appears dependent on serum concentration (Furnari et al., 1997 (Furnari et al., , 1998 Li and Sun, 1998) . In contrast, some breast cancer cell lines expressing wild-type PTEN undergo G1 arrest followed by cell death after the introduction of a wild-type transgene (Weng et al., 1999) . Another study indicated that tumor cell invasion when assayed as a function of expression of PTEN showed that inhibition of invasion by PTEN was similar in U87MG (PTEN null) and LN229 (PTEN expressing) cells (Maier et al., 1999) .
These results suggest that the response to the inhibitory effects of PTEN is highly dependent on cell background and probably on the existence of genetic lesions other than those found in the PTEN gene itself. For example, another important aspect of PTEN alterations noted by several authors is that in many cases where one copy of the PTEN gene is lost, there is a lack of mutation in the second allele. This may be an indication of a second tumor suppressor in the region, that the second allele is silenced, that one allele is not sufficient, or that the protein expressed is deficient for some unknown reason. Our results suggest that the phenotypic penetrance of PTEN expression is highly dependent on cell background, indicating that the accompanying abnormalities may determine the magnitude of PTEN expression necessary to evoke many aspects of its function as a tumor suppressor. While at this time the basis of these varied responses to exogenous PTEN is unknown, understanding these mechanisms will be critical for the design of rational therapeutic strategies.
Here we demonstrate that the response of T24-related cell lines to PTEN extends to regulation of chemotaxis. Serum-induced chemotaxis by T24 and T24T was inhibited by a wild-type PTEN transgene to the same extent as dominant-negative PI3K, indicating that the endogenously expressed PTEN protein is not sufficient to oppose chemotactic signals mediated by PI3K, further arguing for the inactivity of this endogenous protein. The notion that the endogenous PTEN protein in T24/T24T cells is 'functionally deficient' is further supported by our data showing that in cells stably transfected with wild-type PTEN, and exhibiting diminished motility, further exogenous expression achieved via transient transfection of wild-type PTEN does not further affect the motility. These data suggest that T24 cells have a functionally impaired PTEN, which once repaired, further wild-type PTEN expression does not alter their phenotype.
The phenotypes and signaling pathways affected by PTEN are many. The best characterized effects are the attenuation of growth factor stimulation of the PI3K pathway and its downstream effector AKT, resulting in cell cycle arrest and/or apoptosis. This is particularly relevant in this system since, in T24 lineage cells, PI3K is a key mediator of tumor motility in response to EGF (Theodorescu et al., 1998) . The role of PTEN's protein phosphatase activity in tumor suppression is less well understood. Several groups have reported that the protein phosphatase activity encoded by the G129E PTEN mutant can inhibit cell spreading and motility (Tamura et al., 1998 (Tamura et al., , 1999a . Currently, the signaling pathway affected by the protein phosphatase activity is unknown. Since the biological implications of the protein phosphatase activity have not been previously assessed in stably transfected cell lines, perhaps the most interesting aspect of our results is that organotypic and orthotopic invasion in a physiologically relevant system can be inhibited by the protein phosphatase activity of PTEN. Said another way, PTEN can inhibit tumor invasion even in the absence of its lipid phosphatase activity. This translation of motility inhibition to invasion inhibition reconfirms the critical necessity of tumor motility in the development of the invasive phenotype. Importantly, these studies also validate the use of organotypic in vitro approaches as surrogates of in vivo invasion, allowing rapid dissection of the molecular processes leading to invasion while reducing the number of animals previously required for such research.
These findings do not in any way exclude the possibility that the lipid phosphatase activity is not capable of inhibiting motility, since our results concerning the role of PI3K would suggest that it can. In fact, our results suggest a key regulatory role for both lipid and protein activities of PTEN in cell migration and in vivo invasion since reconstitution of both activities (protein phosphatase via transfer of the G129E mutant and lipid phosphatase indirectly via transfer of dominant-negative PI3K) appear to affect cell motility. Direct demonstration of the importance of the lipid phosphatase activity awaits generation of PTEN mutants lacking protein phosphatase activity while maintaining lipid phosphatase activity.
In conclusion, from these data, we can propose a hypothesis where multiple alterations in signaling pathways lead to a progressively more invasive bladder cancer phenotype. For example, a mutated Ras may predispose to increased motility, but this may require EGFR-stimulated signals to fully reach the invasive phenotype. However, the biological impact of these changes would only be manifest if the 'brakes' applied on these multiple signaling pathways are removed, as would be the case with a functionally deficient PTEN, allowing growth factor-induced signals, acting through PI3K and other unidentified effectors, to proceed unabated toward the stimulation of tumor invasion. Fortunately, the putative bifunctional ability of PTEN in suppressing cell migration via both its lipid and protein phosphatase activities indicates that therapeutic targeting of either downstream pathway may lead to inhibition of cellular invasion. Knowledge of these pathways can ultimately lead to a 'window of opportunity' during which therapies to prevent or retard the progression of superficial bladder tumors may be applied.
Materials and methods
Cell lines
All lines used are human bladder cancer. The T24T cell line was recently characterized in our laboratory (Gildea et al., 2000a) as a highly invasive and metastatic variant (Gildea et al., 2002b) of T24. T24, which expresses a functionally deficient PTEN (Liu et al., 2000; Tanaka et al., 2000; Wang et al., 2000) , HT1197 (Liu et al., 2000; Tanaka et al., 2000) , which has a wild-type PTEN, and UM-UC-3 (Liu et al., 2000; Tanaka et al., 2000) , which is null for PTEN, were obtained from the American Tissue Culture Collection (ATCC, Rockville, MD, USA). J82 bladder cancer cells, LNCaP, DU145 and PC-3 human prostate cancer cells were obtained from the American Tissue Culture Collection (ATCC, Rockville, MD, USA). Normal human urothelium cells immortalized by HPV 16 viral oncogene E7 (HUC (HUC E7)) and developed in the laboratory of Dr CA Reznikoff (24) were provided by Dr David Jarrard. T24, T24T and J82 were cultured in DMEM F-12 with 5% fetal calf serum (FCS), HT1197 and UM-UC-3 with DMEM supplemented with sodium pyruvate and 10% FCS, DU145 and PC-3 in DMEM with 10% FCS, LNCaP in T-media with 5% FCS and HUC E7 cells in REGM with Bullet Kit additives. All culture reagents were from Life Technologies (Bethesda, MD, USA) except for the REGM Bullet Kit media which was from BioWhittaker (Walkersville, MD, USA).
Plasmid DNA constructs, transfection, and generation of transient and stable expressing cell lines Dominant-negative PI3K p85 subunit was a generous gift from Dr A Klippel, and is described elsewhere (Kulik et al., 1997) . The PTEN constructs and PBABE vector used for generation of both transient and stable transfections were generous gifts from Drs Frank Furnari and Webster Cavenee and are described elsewhere (Furnari et al., 1997 (Furnari et al., , 1998 . All of the PTEN expression constructs were in the PBABE vector and encode a HA epitope tag c-terminal end of the PTEN protein.
The wild-type PTEN construct (wtPTEN) contains both lipid and protein phosphatase activities. The PTEN expression construct G129E retains the protein phosphatase activity, but has lost the lipid phosphatase activity. The PTEN expression construct G129R has lost both lipid and protein phosphatase activity. For stable transfections, plasmid was linearized and purified on a Qiagen Endo-Free Plasmid Maxi-Kit. For transient transfections, supercoiled plasmids were used. DNA transfections were performed by lipofectin (Life Technologies). Briefly, cells were plated at 6 Â 10 4 cells/well in a six-well plate and allowed to sit down overnight in DMEM-F12 5% FBS. The following morning, the media was changed 2 h before transfection. Lipid DNA mixtures were made according to the manufacturer's instructions. The lipid DNA mixture was incubated with the cells in DMEM phenol red free media for 6 h. Following transfection, cells were washed twice in complete media and allowed to recover overnight. Rapid selection of cells containing transiently transfected plasmid constructs was achieved by the addition of puromycin at 1.7 mg/ml overnight. Cells for stable transfection were selected in 1.7 mg/ml puromycin for 4 weeks. To monitor the effectiveness of transfection and selection, PBABE and pEGFP-N1 (Clontech) were mixed in a 5 : 1 ratio and cotransfected into a replica well. The transfection efficiency before selection was approximately 50%, and after overnight selection greater than 95% of the cells were bright green when visualized by epifluorescence on an inverted microscope using a FITC filter.
Screening for positive PTEN-expressing clones
Approximately 50 wtPTEN, G129E and G129R clones were isolated by limiting dilution. The presence of the construct was initially determined by DNA PCR, using a PTEN-specific foreword primer (5 0 -GAA CTT GCA ATC CTC AGT TTG-3 0 ) and an HA-specific reverse primer (5 0 -AGC GTA ATC TGG AAC ATC GTA-3 0 ). Briefly, the cells were lysed in 1 Â PCR buffer (Sigma, St Louis, MO, USA) containing Proteinase K, incubated at 651C for 1 h, and boiled for 10 min to inactivate the proteinase. PCR amplification was performed from approximately 5000 cell equivalents of lysate, using the manufacturers' reaction conditions (Sigma) and the following protocol: 951C, 5 min followed by 10 cycles of 941C, 30 s; 651C, 30 s; decreasing 11C each cycle, 681C, 2 min then 20 cycles of 941C, 30 s; 551C, 30 s; 681C, 2 min. Transgene expression of positive clones was verified by RT-PCR. RT-PCR was performed using Qiagen One-Step kit using the same primers as above and the same program, except that initially the reactions were incubated at 501C, 30 min then 951C, 15 min before cycling commenced.
Western blotting for PTEN
Western blotting and immunodetection of endogenous PTEN from cell lines was performed as previously described (Seraj et al., 2001 ). Rabbit polyclonal anti-PTEN primary antibody (Cell Signaling, Beverly, MA, USA) was diluted 1 : 500 and the HRP conjugated anti-rabbit secondary antibody at 1 : 100 000. Chemiluminescence was detected with Supersignal West Femto reagent (Pierce, Rockford, IL, USA).
In vitro monolayer growth and colony formation in Agar
Single-cell suspensions were obtained by trypsinization of monolayer cultures, with cell counts performed using a model ZM Coulter Counter. Trypan blue staining was used to assess viability before plating of the cells. After incubation of 375, 750, 1500 and 3000 cells/well in 96-well plates for various times, cell numbers were estimated using the CyQUANT assay (Molecular Probes, Eugene, OR, USA). The media was changed every 2 days. Fluorescence emission was assessed by a fluorescent plate reader (Molecular Dynamics, Sunnyvale, CA, USA). Colony formation in agar containing either 2 or 10% FCS by 1 Â 10 4 cells inoculated into each well of 24-well cell culture plates was carried out using routine methods (Theodorescu et al., 1990) . After 6 weeks of incubation, digital images of the cultures were captured and quantified using ImagePro software (Media Cybernetics, Silver Spring, MD, USA).
Chemotaxis assay
Transwell chemotaxis chambers with 6.5-mm diameter polyvinylpyrrolidone-free polycarbonate filters with 8-mm pore size (Becton Dickinson, Franklin Lakes, NJ, USA) were used for the assay, as we previously described (Gildea et al., 2000b) . In some experiments, cells were transiently transfected with PTEN constructs and the pGL3-CMV construct at a 5 : 1 ratio and then subjected to the rapid overnight selection described above. The pGL3-CMV plasmid constitutively expresses firefly luciferase. The CyQUANT assay measures the total number of cells that move through the membrane, whereas the luciferase assay measures only the cells which were transfected. The motile fraction is defined as the CyQUANT fluorescence or luciferase relative light units (RLU) of cells on the inferior surface of the membrane divided by CyQUANT or luciferase RLU of cells on the replica plate. The upper chamber contained serum-free medium, while the bottom chamber contained medium with 5% serum as the chemoattractant. The CyQUANT and luciferase assays were performed according to the reagent manufacturer's recommendations. Over the course of multiple experiments, we saw no difference in the results obtained by measuring the total number of motile cells by CyQUANT, or the number of motile transfected cells measured by luciferase activity. This is due to the fact that after rapid selection, over 95% of the remaining cells are transfected. Therefore, data given are from CyQUANT assays exclusively.
Bladder organ culture (BOC) assay
Sprague-Dawley rats were anesthetized with urethane, and live bladders harvested under sterile conditions. The bladder was detubularized and glued in one well of a six-well plate, urothelium side up, with cyanoacetate glue. In all, 50 ml of trypsin EDTA in HBSS (Gibco cat #25200-056) was added to the bladder and incubated for 15 min at room temperature. The trypsin was gently aspirated from the edge of the bladder, and any residual trypsin inactivated by 100 ml of 100% FBS. The FBS was removed, and 5 Â 10 5 cells in 100 ml complete media, Waymouths (Gibco cat# 11220-035) with 10% FCS containing antibiotic/antimycotic (Gibco cat# 15240-062) was placed on the bladder surface and incubated for 4 h. After 4 h, 4 ml of complete media was added to each well. The media was changed twice a week for the duration of the experiment. After 3 weeks, the bladders were washed twice with PBS, and fixed overnight in 10% buffered formalin. Routine histological sections were carried out as described (Theodorescu et al., 1990) and examined by a board-certified anatomic pathologist (CAM).
In vivo orthotopic (intravesical) inoculations
Mice were anesthetized and 5 Â 10 6 cells in 50 ml of serum-free media were inoculated orthotopically via a urethral catheter inserted into the bladder as previously described (Theodorescu et al., 1990) . It is important to note that in this assay the cells are deposited in the bladder without any direct inoculation or trauma to the bladder wall, making it an excellent assay to evaluate tumor cell invasion in vivo. At 8 weeks after inoculation, mice were euthanized. For each experimental group (pool or clone), eight mice were used. At the time of euthanasia, tumors were removed on block with adjacent organs and structures in order to evaluate invasion into such organs more accurately. Routine histological sections were carried out as described (Theodorescu et al., 1990) and examined by a board-certified anatomic pathologist (HFF). Sections were captured with ImagePro software using an inverted Zeiss microscope.
Statistical analysis
Statistical comparisons between groups were carried out using either analysis of variance (ANOVA) (Upchurch et al., 1997) or the Student's t-test (Wolf and Smith, 1996) , with or without the Bonferroni correction for multiple comparisons (Ludbrook, 1998) . A difference was considered significant Po0.05. Each experiment included at least two replicate samples and the values represent the average with error bars representing one standard deviation from the mean. Data were plotted and statistical analysis was accomplished using the STATISTICA for Windows computer program (StatSoft, Inc. Tulsa, OK).
